Breakthrough in Fight on Tick-Borne CCHF Virus is Latest Use of New Strategy Against Diseases
A 3D atomic map, or structure, of the Gc protein (red and yellow) bound to two antibodies (green, blue and white) produced by a recovered patient. The Gc protein is a key molecule on the surface of the CCHF virus enabling it to infect cells. Credit: Akaash Mishra/University of Texas at Austin

Using the same approach they recently used to create effective vaccine candidates against COVID-19 and respiratory syncytial virus (RSV), scientists are tackling another virus: the tick-borne Crimean-Congo hemorrhagic fever (CCHF). It causes death in up to 40% of cases, and the World Health Organization identified the disease as one of its top priorities for research and development. The results appear today in the journal Science.